Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.

Xue, Cong

Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. [electronic resource] - Breast cancer research and treatment Feb 2019 - 619-628 p. digital

Publication Type: Journal Article

1573-7217

10.1007/s10549-018-4997-2 doi


Adult
Amenorrhea--blood
Anti-Mullerian Hormone--blood
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor
Breast Neoplasms--blood
Female
Follow-Up Studies
Humans
Menstrual Cycle--metabolism
Middle Aged
Neoplasm Staging
Nomograms
Premenopause
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Young Adult